Centre for Cancer Biomarkers CCBIO

2014 - Ingrid Moen

Born 1982, holds a M.S. in experimental- and human physiology from UiB and finished her PhD at UiB in 2011 on the influence of oxygen in breast cancer development, using hyperbaric oxygen treatment. She was a post-doc in the Reed group until December 2014 and was there investigating the effect of a novel focal adhesion kinase inhibitor on metastasis.

Main content

Ingrid moved on to the biotechnology company Oxy Solutions as senior researcher. 


Read here about Ingrid Moen's publications and more.